Lifitegrast

Nomen chemicum (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl) phenyl ) Propanoicum acidum

CAS： 1025967-78-5

Comitatu inquisitionis originalis: Comitatus Pharmaceutical Comitatus, UK

Commercium nomen, Xiidra

Registration classificationis: Materiae rudis pro 3 categoriis, oculi guttae pro 3 categoriis.

Dosis specificatio: 50mg / mL(5%), 0.2ml/, 5 per sacculum, 60 per capsam.

Indicatio: Xiidra (solutio oculi lifitegrasti) 5% est functionis lymphocytae antigeni-1 (LFA-1) adversario curationi signorum et symptomata morborum oculi sicci (DED